US$ 23.51
glp 1 tirzepatide vs semaglutide ๐ Which treatment is right for you? โซ๏ธ is a GLP-1 receptor agonist that mimics a hormone to regulate appetite and blood sugar. โซ๏ธ is a dual GIP and GLP-1 Tirzepatide vs Semaglutide for Weight
Description
For post-cholecystectomy patients considering GLP-1 therapy, understanding your baseline metabolic healthincluding liver enzymes, lipid profiles, and pancreatic functionbecomes especially important

GIP (Glucose-dependent Insulinotropic Polypeptide): The addition of GIP agonism provides synergistic effects

The evidence is fairly clear that people regain weight once they go off GLP-1s
Aspirin defined the first era by targeting inflammation
Coordination with endocrinology, primary care, or the prescribing clinician may be appropriate for patients with poor glycemic control, insulin use, chronic kidney disease, or high cardiovascular risk

Some patients find success with a 'step-down' protocol: maintaining their therapeutic dose for several weeks after goal weight, then reducing by 25% every 2-3 weeks until discontinuation